Different pathways mediate cytochrome c release after photodynamic therapy with hypericin

Photochemistry and Photobiology

Volumn 74, Issue 2, 2001, Pages 133-142

  Vantieghem, Annelies ^a   Xu, Yan ^a   Declercq, Wim ^b   Vandenabeele, Peter ^b   Denecker, Geertrui ^b   Vandenheede, Jackie R ^a   Merlevede, Wilfried ^a   De Witte, Peter A ^a   Agostinis, Patrizia ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE INHIBITOR; CYCLOSPORIN A; CYTOCHROME C; HYPERICIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME RELEASE; INCUBATION TIME; MITOCHONDRION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; RAT;

ANIMALS; CASPASE 3; CASPASES; CELL DEATH; CELL LINE; CYTOCHROME C GROUP; ENZYME ACTIVATION; ENZYME PRECURSORS; GENES, BCL-2; HYBRIDOMAS; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; PERYLENE; PHOTOCHEMOTHERAPY; POLY(ADP-RIBOSE) POLYMERASES; RATS; SERPINS; TRANSFECTION; VIRAL PROTEINS;

ANIMALIA;

EID: 0035437553     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2001)074<0133:DPMCCR>2.0.CO;2     Document Type: Conference Paper

References (54)

1. Oleinick, N. L. and H. H. Evans (1998) The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 150, S146-S156.
2. Lavie, G., Y. Mazur, D. Lavie and D. Meruelo (1995) The chemical and biological properties of hypericin - a compound with a broad spectrum of biological activities. Med. Res. Rev. 15, 111-119.
3. Giese, A. C. (1980) Hypericism. Photochem. Photobiol. Rev. 5, 229-255.
4. Meruelo, D., G. Lavie and D. Lavie (1988) Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 85, 5230-5234.
5. Duran, N. and P. Song (1986) Hypericin and its photodynamic action. Photochem. Photobiol. 53, 677-680.
6. Thomas, C., R. Macgill, C. Miller and R. Pardini (1992) Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem. Photobiol. 55, 47-53.
7. Sureau, F., P. Miskovsky, L. Chinsky and P.-Y. Turpin (1996) Hypericin-induced cell photosensitization involves an intracellular pH decrease. J. Am. Chem. Soc. 118, 9484-9487.
8. Chaloupka, R., T. Obsil, J. Plasek and F. Sureau (1999) The effect of hypericin and hypocrellin-A on lipid membranes and membrane potential of 3T3 fibroblasts. Biochim. Biophys. Acta 1418, 39-47.
9. Hadjur, C., M. J. Richard, M. O. Parat, A. Favier and P. Jardon (1995) Photodynamically induced cytotoxicity of hypericin dye on human fibroblast cell line MRC5. J. Photochem. Photobiol. B: Biol. 27, 139-146.
10. Andreoni, A., A. Colasanti, P. Colasanti, M. Mastrocinque, P. Riccio and G. Roberti (1994) Laser photosensitization of cells by hypericin. Photochem. Photobiol. 59, 529-533.
11. Yu, H., S. T. Wolford, R. Kegode, W. Zhao and G. D. Osweiler (1996) Hypericin-induced phototoxicity in cultured fibroblasts and swine erythrocytes. Photochem. Photobiol. 64, 168-173.
12. Vandenbogaerde, A., P. Proot, B. Himpens, W. Merlevede and P. de Witte (1997) Differential cytotoxic effects induced after photosenstization with hypericin. J. Photochem. Photobiol. B: Biol. 38, 136-142.
13. Vandenbogaerde, A., K. Geboes, J. Cuveele, P. Agostinis, W. Merlevede and P. de Witte (1996) Antitumor activity of photosensitized hypericin on A431 cell xenografts. Anticancer Res. 16, 1619-1626.
14. Alecu, M., C. Ursaciuc, F. Hãlãlãu, G. Coman, W. Merlevede, E. Waelkens and P. de Witte (1998) Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res. 18, 4651-4654.
15. Chen, B. and P. A. de Witte (2000) Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. Cancer Lett. 150, 111-117.
16. D'Hallewin, M. A., P. A. de Witte, E. Waelkens, W. Merlevede and L. Baert (2000) Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J. Urol. 164, 349-351.
17. Green, D. and J. Reed (1998) Mitochondria and apoptosis. Science 275, 1309-1312.
18. Yang, J. and G. Cortopassi (1998) Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic. Biol. Med. 24, 624-631.
19. Vander Heiden, M. G., N. S. Chandel, E. K. Williamson, P. T. Schumacker and C. B. Thompson (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-637.
20. Zamzami, N., P. Marchetti, M. Castedo, T. Hirsch, S. A. Susin, B. Masse and G. Kroemer (1996) Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384, 53-57.
21. Bernardi, P., L. Scorrano, R. Colonna, V. Petronilli and F. Di Lisa (1999) Mitochondria and cell death. Eur. J. Biochem. 264, 687-701.
22. Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri and X. Wang (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
23. Hu, Y., M. A. Benedict, L. Ding and G. Núñez (1999) Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 18, 3586-3595.
24. Reed, J. C. (1998) Bcl-2 family proteins. Oncogene 17, 3225-3236.
25. Kluck, R. M., E. Bossy-Wetzel, D. R. Green and D. D. Newmeyer (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136.
26. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones and X. Wang (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
27. Hockenbery, D. M., Z. N. Oltvai, X.-M. Yin, C. L. Milliman and S. J. Korsmeyer (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
28. Kane, D. J., T. A. Sarafian, R. Anton, H. Hahn, E. B. Gralla, J. S. Valentin, T. Ord and D. E. Bredesen (1993) Bcl-2 inhibition of neuronal death: decreased generation of reactive oxygen species. Science 262, 1274-1277.
29. Zamzami, N., I. Marzo, S. A. Susin, C. Brenner, N. Larochette, P. Marchetti, J. Reed, R. Kofler and G. Kroemer (1998) The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene 16, 1055-1063.
30. Kane, D. J., T. Ord, R. Anton and D. E. Bredesen (1995) Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40, 269-275.
31. Shimizu, S., Y. Eguchi, W. Kamiike, S. Waguri, Y. Uchiyama, H. Matsuda and Y, Tsujimoto (1996) Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 12, 2045-2050.
32. Miccoli, L., A. Beurdeley-Thomas, G. De Pinieux, F. Sureau, S. Oudard, B. Dutrillaux and M. Poupon (1998) Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res. 58, 5777-5786.
33. Johnson, S. A., A. E. Dalton and R. S. Pardini (1998) Timecourse of hypericin phototoxicity and effect on mitochondrial energies in EMT6 mouse mammary carcinoma cells. Free Radic. Biol. Med. 25, 144-152.
34. Vantieghem, A., Z. Assefa, P. Vandenabeele, W. Declercq, S. Courtois, J. R. Vandenheede, W. Merlevede, P. de Witte and P. Agostinis (1998) Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett. 440, 19-24.
35. Assefa, Z., A. Vantieghem, W. Declercq, P. Vandenabeele, J. R. Vandenheede, W. Merlevede, P. de Witte and P. Agostinis (1999) The activation of the c-Jun N-terminal kinase and p38 MAPK signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J. Biol. Chem. 274, 8788-8796.
36. Falk, H., J. Meyer and M. Oberreiter (1993) A convenient semisynthetic route to hypericin. Monatsh. Chem. 124, 339-341.
37. Vandenabeele, P., W. Declercq, B. Vanhaesebroeck, J. Grooten and W. Fiers (1995) Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol. 154, 2904-2913.
38. Steemans, M., V. Goossens, M. Van de Craen, F. Van Herreweghe, K. Vancompernolle, K. De Vos, P. Vandenabeele and J. Grooten (1998) A caspase-activated factor (CAF) induces mitochondrial membrane depolarization and cytochrome c release by a nonproteolytic mechanism. J. Exp. Med. 188, 2193-2198.
39. Zhou, Q., S. Snipas, K. Orth, M. Muzio, V. M. Dixit and G. S. Salvesen (1997) Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272, 7797-7800.
40. Furlong, I. J., C. Lopez Mediavilla, R. Ascaso, A. Lopez Rivas and M. K. Collins (1998) Induction of apoptosis by valinomycin: mitochondrial permeability transition causes intracellular acidification. Cell Death Differ. 5, 214-221.
41. Fadeel, B., Z. Hassan, E. Hellström-Lindberg, J.-I. Henter, S. Orrenius and B. Zhivotovsky (1999) Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. Leukemia 13, 719-728.
42. Fujita, N. and T. Tsuruo (1998) Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem. Biophys. Res. Commun. 246,484-488.
43. Grandgirard, D., E. Studer, L. Monney, T. Belser, I. Fellay, C. Borner and M. R. Michel (1998) Alphaviruses induce apoptosis in Bcl-2 overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J. 17, 1268-1278.
44. Kim, H. C., Y. Luo, G. Li and D. Kessel (1999) Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. Cancer Res. 59, 3429-3432.
45. Luo, X., I. Budihardjo, H. Zou, C. Slaughter and X. Wang (1998) Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490.
46. Marzo, I., S. A. Susin, P. X. Petit, L. Ravagnan, C. Brenner, N. Larochette, N. Zamzami and G. Kroemer (1998) Caspases disrupt mitochondrial membrane barrier function. FEBS Lett. 427, 198-202.
47. Reed, J. C., J. M. Jurgensmeier and S. Matsuyama (1998) Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta 1366, 127-137.
48. Chaloupka, R., P. X. Petit, N. Israel and F. Sureau (1999) Overexpression of Bcl-2 does not protect cells from hypericin photoinduced mitochondrial membrane depolarization, but delays subsequent events in the apoptotic pathway. FEBS Lett. 462, 295-301.
49. He, J., M. L. Agarwal, H. E. Larkin, L. E. Friedman, L. Y. Xue and N. L. Oleinick (1996) The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2. Photochem. Photobiol. 64, 845-852.
50. Granville, D. J., H. Jiang, M. T. An, J. G. Levy, B. M. McManus and D. W. C. Hunt (1999) Bcl-2 overexpression blocks caspase activation and downstream events instigated by photodynamic therapy. Br. J. Cancer 79, 95-100.
51. L overexpression do not prevent early mitochondrial events but still depress caspase activity. Lab. Invest. 79, 953-965.
52. Chen, Q., B. Gong and A. Almasan (2000) Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell Death Differ. 7, 227-233.
53. Susin, S. A., H. L. Lorenzo, N. Zamzami, I. Marzo, B. E. Snow, G. M. Brothers, J. Mangion, E. Jacotot, P. Constantini, M. Loeftler, N. Larochette, D. R. Goodlett, R. Aebersold, D. P. Siderovski, J. M. Penninger and G. Kroemer (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446.
54. Wang, K. K. (2000) Calpain and caspase: can you tell the difference? Trends Neurosci. 23, 20-26.